...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question
Reply New Message
Prev Message Back To Forum Threaded View Next Message

At this point , all I care is that Zenith Managment is working to finalize a buyout or major partnership deal with a BP. All this confusion  will take care of its self after that i would assume

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply